|Preferred IUPAC name
3D model (Jmol)
|Molar mass||110.11 g·mol−1|
|Density||1.3 g cm−3, solid|
|Melting point||172 °C (342 °F; 445 K)|
|Boiling point||287 °C (549 °F; 560 K)|
|5.9 g/100 mL (15 °C)|
|Vapor pressure||0.00001 mmHg (20°C)|
Carc. Cat. 3
Muta. Cat. 3
the environment (N)
|R-phrases (outdated)||R22 R40 R41 R43 R50 R68|
|S-phrases (outdated)||(S2) S26 S36/37/39 S61|
|Flash point||165 °C (329 °F; 438 K)|
|Lethal dose or concentration (LD, LC):|
LD50 (median dose)
|490 mg/kg (mammal, oral)
245 mg/kg (mouse, oral)
200 mg/kg (rabbit, oral)
320 mg/kg (rat, oral)
550 mg/kg (guinea pig, oral)
200 mg/kg (dog, oral)
70 mg/kg (cat, oral)
|US health exposure limits (NIOSH):|
|TWA 2 mg/m3|
|C 2 mg/m3 [15-minute]|
IDLH (Immediate danger)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Hydroquinone, also benzene-1,4-diol or quinol, is an aromatic organic compound that is a type of phenol, a derivative of benzene, having the chemical formula C6H4(OH)2. It has two hydroxyl groups bonded to a benzene ring in a para position. It is a white granular solid. Substituted derivatives of this parent compound are also referred to as hydroquinones. The name "hydroquinone" was coined by Friedrich Wöhler in 1843.
Hydroquinone is produced industrially by two main routes.
- The most widely used route is similar to the cumene process in reaction mechanism and involves the dialkylation of benzene with propene to give 1,4-diisopropylbenzene. This compound reacts with air to afford the bis(hydroperoxide), which is structurally similar to cumene hydroperoxide and rearranges to give acetone and hydroquinone in acid.
- A second route involves hydroxylation of phenol. The conversion uses hydrogen peroxide and affords a mixture of hydroquinone and catechol:
- C6H5OH + H2O2 → C6H4(OH)2 + H2O
Other, less common methods include:
- The oxidation of aniline by manganese dioxide followed by reduction of the resulting 1,4-benzoquinone. The process is conducted batchwise and generates a substantial waste stream.
- A potentially significant synthesis of hydroquinone from acetylene and iron pentacarbonyl has been proposed Iron pentacarbonyl serves as a catalyst, rather than as a reagent, in the presence of free carbon monoxide gas. Rhodium or ruthenium can substitute for iron as the catalyst with favorable chemical yields but are not typically used due to their cost of recovery from the reaction mixture.
- Hydroquinone and its derivatives can also be prepared by oxidation of various phenols. Examples include Elbs persulfate oxidation and Dakin oxidation:
- Hydroquinone was first obtained in 1820 by the French chemists Pelletier and Caventou via the dry distillation of quinic acid.
The reactivity of hydroquinone's O-H groups resembles other phenols, being weakly acidic. The resulting conjugate base undergoes easy O-alkylation to give mono- and diethers. Similarly, hydroquinone is highly susceptible to ring substitution by Friedel-Crafts reactions such as alkylation. This reaction is exploited en route to popular antioxidants such as 2-tert-butyl-4-methoxyphenol ("BHA"). The useful dye quinizarin is produced by diacylation of hydroquinone with phthalic anhydride
Hydroquinone undergoes oxidation under mild conditions to give benzoquinone. This process can be reversed. Some naturally occurring hydroquinone derivatives exhibit this sort of reactivity, one example being coenzyme Q. Industrially this reaction is exploited both with hydroquinone itself but more often with its derivatives where one OH has been replaced by an amine.
- C6H4(OH)2 + CH3NH2 → C6H4(OH)(N(H)CH3) + H2O
Similarly diamines, useful in the rubber industry as antiozone agents, are produced similarly from aniline:
- C6H4(OH)2 + 2 C6H5NH2 → C6H4(N(H)C6H5)2 + 2 H2O
Hydroquinone has a variety of uses principally associated with its action as a reducing agent that is soluble in water. It is a major component in most black and white photographic developers for film and paper where, with the compound metol, it reduces silver halides to elemental silver.
There are various other uses associated with its reducing power. As a polymerization inhibitor, hydroquinone prevents polymerization of acrylic acid, methyl methacrylate, cyanoacrylate, and other monomers that are susceptible to radical-initiated polymerization. This application exploits the antioxidant properties of hydroquinone.
Hydroquinone can undergo mild oxidation to convert to the compound parabenzoquinone, C6H4O2, often called p-quinone or simply quinone. Reduction of quinone reverses this reaction back to hydroquinone. Some biochemical compounds in nature have this sort of hydroquinone or quinone section in their structures, such as Coenzyme Q, and can undergo similar redox interconversions.
Hydroquinone is used as a topical application in skin whitening to reduce the color of skin. It does not have the same predisposition to cause dermatitis as metol does. This is a prescription only ingredient in some countries, including the member states of the European Union under Directives 76/768/EEC:1976.
In 2006, the United States Food and Drug Administration revoked its previous approval of hydroquinone and proposed a ban on all over-the-counter preparations. The FDA stated that hydroquinone cannot be ruled out as a potential carcinogen. This conclusion was reached based on the extent of absorption in humans and the incidence of neoplasms in rats in several studies where adult rats were found to have increased rates of tumours, including thyroid follicular cell hyperplasias, anisokaryosis (variation in nuclei sizes), mononuclear cell leukemia, hepatocellular adenomas and renal tubule cell adenomas. The Campaign for Safe Cosmetics has also highlighted concerns.
Numerous studies have revealed that hydroquinone can cause exogenous ochronosis, a disfiguring disease in which blue-black pigments are deposited onto the skin, if taken orally; however, skin preparations containing the ingredient are administered topically. The FDA has classified hydroquinone in 2006 as a safe product - generally recognized as safe and effective (GRASE), however additional studies under the National Toxicology Program (NTP) were suggested in order to determine whether there is a risk to humans from the use of hydroquinone. NTP evaluation showed some evidence of long-term carcinogenic and genotoxic effects
While using hydroquinone as a lightening agent can be effective with proper use, it can also cause skin sensitivity. Using a daily sunscreen with a high PPD (persistent pigment darkening) rating reduces the risk of further damage. Hydroquinone is sometimes combined with alpha hydroxy acids that exfoliate the skin to quicken the lightening process. In the United States, topical treatments usually contain up to 2% in hydroquinone. Otherwise, higher concentrations (up to 4%) should be prescribed and used with caution.
While hydroquinone remains widely prescribed for treatment of hyperpigmentation, questions raised about its safety profile by regulatory agencies in the EU, Japan, and USA encourage the search for other agents with comparable efficacy. Several such agents are already available or under research, including azelaic acid, kojic acid, retinoids, cysteamine, topical steroids, glycolic acid, and other substances.
Hydroquinones are one of the two primary reagents in the defensive glands of bombardier beetles, along with hydrogen peroxide (and perhaps other compounds, depending on the species), which collect in a reservoir. The reservoir opens through a muscle-controlled valve onto a thick-walled reaction chamber. This chamber is lined with cells that secrete catalases and peroxidases. When the contents of the reservoir are forced into the reaction chamber, the catalases and peroxidases rapidly break down the hydrogen peroxide and catalyze the oxidation of the hydroquinones into p-quinones. These reactions release free oxygen and generate enough heat to bring the mixture to the boiling point and vaporize about a fifth of it, producing a hot spray from the beetle's abdomen.
In bearberry (Arctostaphylos uva-ursi), arbutin is converted to hydroquinone.
- Nomenclature of Organic Chemistry : IUPAC Recommendations and Preferred Names 2013 (Blue Book). Cambridge: The Royal Society of Chemistry. 2014. p. 691. doi:10.1039/9781849733069-FP001. ISBN 978-0-85404-182-4.
- "NIOSH Pocket Guide to Chemical Hazards #0338". National Institute for Occupational Safety and Health (NIOSH).
- Lander, John J.; Svirbely, John J. Lander, W. J. (1945). "The Dipole Moments of Catechol, Resorcinol and Hydroquinone". Journal of the American Chemical Society. 67 (2): 322–324. doi:10.1021/ja01218a051.
- "Hydroquinone". Immediately Dangerous to Life and Health. National Institute for Occupational Safety and Health (NIOSH).
- F. Wöhler (1844) "Untersuchungen über das Chinon" (Investigations of quinone), Annalen der Chemie und Pharmacie, 51 : 145-163. From page 146: "Das so erhaltene Destillat … enthält … einen neuen, krystallisierenden Körper, den ich unter dem Namen farbloses Hydrochinon weiter unten näher beschreiben werde." (The distillate so obtained … contains … a new, crystallizable substance, that I will describe, under the name of colorless hydroquinone, further below in more detail.) [Note: Wöhler's empirical formula for hydroquinone (p. 152) is incorrect because (1) he attributed 25 (instead of 24) carbon atoms to the molecule, and (2) as many chemists at the time did, he used the wrong atomic masses for carbon (6 instead of 12) and oxygen (8 instead of 16). With these corrections, his empirical formula becomes: C12H12O4. Dividing the subscripts by 2, the result is: C6H6O2 , which is correct.]
- Phillip M. Hudnall "Hydroquinone" in Ullmann's Encyclopedia of Industrial Chemistry 2002, Wiley-VCH, Weinheim. 2005 Wiley-VCH, Weinheim. doi:10.1002/14356007.a13_499.
- Reppe, Walter; Kutepow, N; Magin, A (1969). "Cyclization of Acetylenic Compounds". Angewandte Chemie International Edition in English. 8 (10): 727–733. doi:10.1002/anie.196907271. Retrieved 26 December 2013.
- Hubel, Karl; Braye, Henri (1960). Process for the preparation of substituted cyclic compounds and products resulting therefrom US3149138 A (PDF). Union Carbide Corp.
- Pino, Piero; Braca, Giuseppe; Sbrana, Glauco (1964). Preparation of hydroquinone US3355503 A (PDF). Lonza Ag.
- Walter, Reppe; Magin, August (1966). Production of hydroquinones US3394193 A (PDF). Basf Ag.
- Piero, Pino; Giuseppe, Braca; Frediano, Settimo; Glauco, Sbrana (1967). Preparation of hydroquinone US3459812 A (PDF). Lonza Ag.
- Holmes, J.; Hagemeyer, H. (1971). Process for the production of hydroquinone US 3742071 A (PDF). Eastman Kodak Co.
- Pelletier and Caventou (1820) "Recherches chimiques sur les quinquinas" (Chemical investigations of quinquinas [i.e., the bark of various Cinchona trees]), Annales de Chimie et de Physique, 2nd series, 15 : 289-318, 337-364. On pages 341-342, the preparation and properties of l'acide pyro-kinique (pyroquinic acid or hydroquinone) are discussed.
- Roscoe, Henry (1891). A Treatise on Chemistry, Volume 3, Part 3. London: Macmillan & Co. p. 165.
- 76/768/EEC:1976 Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products : http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31976L0768:EN:HTML
- Example of a product recall in Ireland
- United States Food and Drug Administration (2006). Skin Bleaching Drug Products for Over-the-Counter Product Use; Proposed Rule (PDF) (Report). 1978N-0065.
- Research, Center for Drug Evaluation and. "About the Center for Drug Evaluation and Research - Hydroquinone Studies Under The National Toxicology Program (NTP)". www.fda.gov. Retrieved 2017-02-12.
- Campaign For Safe Cosmetics - Hydroquinone
- Olumide, YM; Akinkugbe, AO; Altraide, D; Mohammed, T; Ahamefule, N; Ayanlowo, S; Onyekonwu, C; Essen, N (April 2008). "Complications of chronic use of skin lightening cosmetics". International Journal of Dermatology. 47 (4): 344–53. doi:10.1111/j.1365-4632.2008.02719.x. PMID 18377596.
- "Hydroquinone 10022-H". ntp.niehs.nih.gov. Retrieved 2017-02-12.
- Draelos, Zoe Diana (2007-09-01). "Skin lightening preparations and the hydroquinone controversy". Dermatologic Therapy. 20 (5): 308–313. doi:10.1111/j.1529-8019.2007.00144.x. ISSN 1529-8019. PMID 18045355.
- Bandyopadhyay, Debabrata (2009-01-01). "TOPICAL TREATMENT OF MELASMA". Indian Journal of Dermatology. 54 (4): 303–309. doi:10.4103/0019-5154.57602. ISSN 0019-5154. PMC . PMID 20101327.
- Mazurek, Klaudia; Pierzchała, Ewa (2016-09-01). "Comparison of efficacy of products containing azelaic acid in melasma treatment". Journal of Cosmetic Dermatology. 15 (3): 269–282. doi:10.1111/jocd.12217. ISSN 1473-2165. PMID 27028014.
- Mansouri, P.; Farshi, S.; Hashemi, Z.; Kasraee, B. (2015-07-01). "Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial". The British Journal of Dermatology. 173 (1): 209–217. doi:10.1111/bjd.13424. ISSN 1365-2133. PMID 25251767.
- Organic Chemistry, Solomon and Fryhle, 10th edition, Wiley Publishing, 2010.[page needed]
- Joval, E; Kroeger, P; N (April 1996). "Hydroquinone: the toxic compound of Agaricus hondensis". Planta Medica. 62 (2): 185. doi:10.1055/s-2006-957852. PMID 17252436.
- Burdock, G.A. (1998). "Review of the biological properties and toxicity of bee propolis (propolis)". Food and Chemical Toxicology. 36 (4): 347–363. doi:10.1016/S0278-6915(97)00145-2. PMID 9651052.
- The Beaver: Its Life and Impact. Dietland Muller-Schwarze, 2003, page 43 (book at google books)